Atıf Formatları
HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION USING A REDUCED-INTENSITY CONDITIONING REGIMEN WHICH CONSIST OF RITUXIMAB AND MESENCYMAL STEM CELL CO-INFUSION IN CHILDREN: PRELIMINARY RESULTS
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

F. Erbey Et Al. , "HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION USING A REDUCED-INTENSITY CONDITIONING REGIMEN WHICH CONSIST OF RITUXIMAB AND MESENCYMAL STEM CELL CO-INFUSION IN CHILDREN: PRELIMINARY RESULTS," PEDIATRIC BLOOD & CANCER , vol.62, 2015

Erbey, F. Et Al. 2015. HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION USING A REDUCED-INTENSITY CONDITIONING REGIMEN WHICH CONSIST OF RITUXIMAB AND MESENCYMAL STEM CELL CO-INFUSION IN CHILDREN: PRELIMINARY RESULTS. PEDIATRIC BLOOD & CANCER , vol.62 .

Erbey, F., Atay, D., Akcay, A., Ovali, E., & Oeztuerk, G., (2015). HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION USING A REDUCED-INTENSITY CONDITIONING REGIMEN WHICH CONSIST OF RITUXIMAB AND MESENCYMAL STEM CELL CO-INFUSION IN CHILDREN: PRELIMINARY RESULTS. PEDIATRIC BLOOD & CANCER , vol.62.

Erbey, F. Et Al. "HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION USING A REDUCED-INTENSITY CONDITIONING REGIMEN WHICH CONSIST OF RITUXIMAB AND MESENCYMAL STEM CELL CO-INFUSION IN CHILDREN: PRELIMINARY RESULTS," PEDIATRIC BLOOD & CANCER , vol.62, 2015

Erbey, F. Et Al. "HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION USING A REDUCED-INTENSITY CONDITIONING REGIMEN WHICH CONSIST OF RITUXIMAB AND MESENCYMAL STEM CELL CO-INFUSION IN CHILDREN: PRELIMINARY RESULTS." PEDIATRIC BLOOD & CANCER , vol.62, 2015

Erbey, F. Et Al. (2015) . "HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION USING A REDUCED-INTENSITY CONDITIONING REGIMEN WHICH CONSIST OF RITUXIMAB AND MESENCYMAL STEM CELL CO-INFUSION IN CHILDREN: PRELIMINARY RESULTS." PEDIATRIC BLOOD & CANCER , vol.62.

@article{article, author={F. Erbey Et Al. }, title={HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION USING A REDUCED-INTENSITY CONDITIONING REGIMEN WHICH CONSIST OF RITUXIMAB AND MESENCYMAL STEM CELL CO-INFUSION IN CHILDREN: PRELIMINARY RESULTS}, journal={PEDIATRIC BLOOD & CANCER}, year=2015}